These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 195174)

  • 1. Amphetamine inhibition of alpha-bungarotoxin binding at the mouse neuromuscular junction.
    Skau KA; Gerald MC
    Life Sci; 1977 May; 20(9):1495-9. PubMed ID: 195174
    [No Abstract]   [Full Text] [Related]  

  • 2. Curare-like effects of the amphetamine isomers on neuromuscular transmission.
    Skau KA; Gerald MC
    Neuropharmacology; 1978; 17(4-5):271-6. PubMed ID: 206858
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of amphetamine isomers on neuromuscular transmission.
    Gerrald M; Hsu SY
    Neuropharmacology; 1975 Feb; 14(2):115-23. PubMed ID: 168508
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction.
    Quik M; Collier B; Audhya T; Goldstein G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1113-9. PubMed ID: 1967127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of (+)-amphetamine enhancement of neuromuscular transmission: muscle contraction, electrophysiological and biochemical results.
    Snider RM; Gerald MC
    J Pharmacol Exp Ther; 1982 Apr; 221(1):14-21. PubMed ID: 6121051
    [No Abstract]   [Full Text] [Related]  

  • 6. Department of Pharmacology, The School of Pharmacy, University of London, London, Great Britain.
    Brown DA; Fumagalli L
    Brain Res; 1977 Jun; 129(1):165-8. PubMed ID: 194659
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of alpha-bungarotoxin binding to rat and mouse diaphragms by amphetamine and related nonquaternary compounds.
    Skau KA; Gerald MC
    J Pharmacol Exp Ther; 1978 Apr; 205(1):69-76. PubMed ID: 633090
    [No Abstract]   [Full Text] [Related]  

  • 8. The depressant action of morphine on transmission at a skeletal neuromuscular junction is non-specific.
    Bell KM; Rees JM
    J Pharm Pharmacol; 1974 Sep; 26(9):686-91. PubMed ID: 4155745
    [No Abstract]   [Full Text] [Related]  

  • 9. Discrimination between nicotinic receptors in vertebrate ganglia and skeletal muscle by alpha-bungarotoxin and cobra venoms.
    Bursztajn S; Gershon MD
    J Physiol; 1977 Jul; 269(1):17-31. PubMed ID: 894538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions.
    Albuquerque EX; Barnard EA; Chiu TH; Lapa AJ; Dolly JO; Jansson SE; Daly J; Witkop B
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):949-53. PubMed ID: 4351811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and nalorphine impair neuromuscular transmission.
    Pinsky C; Frederickson RC
    Nat New Biol; 1971 May; 231(20):94-6. PubMed ID: 4325657
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo recovery of muscle contraction after alpha-bungarotoxin binding.
    Fertuck HC; Woodward W; Salpeter MM
    J Cell Biol; 1975 Jul; 66(1):209-13. PubMed ID: 1141378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of the snake neuromuscular junction to the blocking effect of beta-bungarotoxin.
    Xu K; Shih YL
    Jpn J Physiol; 1992; 42(3):535-8. PubMed ID: 1331584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counting bungarotoxin binding sites of nicotinic acetylcholine receptors in mammalian cells with high signal/noise ratios.
    Simonson PD; Deberg HA; Ge P; Alexander JK; Jeyifous O; Green WN; Selvin PR
    Biophys J; 2010 Nov; 99(10):L81-3. PubMed ID: 21081055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Bungarotoxin antagonizes the effect of alpha-latrotoxin from black widow spider venom on the neuromuscular junction.
    Tzeng MC; Tian SS
    J Neurobiol; 1984 Mar; 15(2):157-60. PubMed ID: 6325594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of neuromuscular transmission with evoked electromyography--11. Comparison between blocks by magnesium and by pancuronium].
    Shiraishi H; Katsumata N; Suzuki T; Ogawa S; Suzuki H
    Masui; 1994 Apr; 43(4):538-46. PubMed ID: 8189619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The marine phycotoxin gymnodimine targets muscular and neuronal nicotinic acetylcholine receptor subtypes with high affinity.
    Kharrat R; Servent D; Girard E; Ouanounou G; Amar M; Marrouchi R; Benoit E; Molgó J
    J Neurochem; 2008 Nov; 107(4):952-63. PubMed ID: 18990115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
    Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
    Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine effects on acetylcholine release and mammalian neuromuscular transmission.
    Snider RM; Gerald MC
    Life Sci; 1981 Oct; 29(16):1661-8. PubMed ID: 6273675
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
    Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.